Grail to cut jobs, planned hires for 2024 by about 30%
Aug 13 (Reuters) - Cancer test maker Grail GRAL.O said on Tuesday it would reduce existing headcount and planned hires for 2024 by about 30%, as part of its restructuring program. (Reporting by Christy Santhosh; Editing by Shilpi Majumdar) ((Christy.Santhosh@thomsonreuters.com;))
Recent news on Grail
See all newsGrail rises as TD Cowen more than doubles PT on FDA, Medicare optimism
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
U.S. RESEARCH ROUNDUP-Chevron, Mobility Global, Tesla
Street View: Grail cancer test's progress boosts prospects for multi-cancer detection market
NASDAQ RESUMED AT 07:05 AM